-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/3_TK2_T4-Quarterly_or_Monthly_Prescribing_Profile_Final.docx
October 01, 2016 - Tool 4. Quarterly or Monthly Prescribing Profile
[Date]
From: [Nursing Home Name]
Dear Dr./Mr./Ms. [insert last name of prescribing clinician]
This [quarterly / monthly] report is provided for your reference as we continue to monitor antibiotic use in our nursing home.
Between 25 percent and 75 percent of antibiotics a…
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/3_TK2_T4-Quarterly_or_Monthly_Prescribing_Profile_Final.pdf
October 01, 2016 - Nursing Home
Antimicrobial Stewardship Guide
Implement, Monitor, & Sustain a Program
Toolkit 2. Monitor and Sustain Stewardship
Tool 4. Quarterly or Monthly Prescribing Profile
[Date]
From: [Nursing Home Name]
Dear Dr./Mr./Ms. [insert last name of prescribing clinician]
This [quarterly / monthly] repo…
-
psnet.ahrq.gov/node/40236/psn-pdf
March 23, 2012 - The safety implications of missed test results for
hospitalised patients: a systematic review.
March 23, 2012
Callen J, Georgiou A, Li J, et al. The safety implications of missed test results for hospitalised patients: a
systematic review. BMJ Qual Saf. 2011;20(2):194-199. doi:10.1136/bmjqs.2010.044339.
https://ps…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sN6DG_LdfFyf98hhVQjetB
Screening for Lung Cancer: Clinical Summary of USPSTF Recommendation
SCREENING FOR LUNG CANCER
CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION
Population Asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and
currently smoke or have quit smoking within the…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f-surv-rept-1-acute-pain.xlsx
October 08, 2025 - F-1. RCT QA
Table F-1. Risk of bias assessment for randomized controlled trials
Author, Year
(Full Citations Are Listed in Appendix C.) Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Reporting of Attrition, Crossove…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/rLjXX_3oMKssbHxrj84UYA
Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes: Clinical Summary
Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes:
Clinical Summary
Population Asymptomati…
-
psnet.ahrq.gov/node/46709/psn-pdf
December 22, 2018 - Association between treatment by locum tenens internal
medicine physicians and 30-day mortality among
hospitalized Medicare beneficiaries.
December 22, 2018
Blumenthal DM, Olenski AR, Tsugawa Y, et al. Association Between Treatment by Locum Tenens Internal
Medicine Physicians and 30-Day Mortality Among Hospitalize…
-
psnet.ahrq.gov/node/847544/psn-pdf
April 12, 2023 - A nationwide study of the "July Effect" concerning
postpartum hemorrhage and its risk factors at teaching
hospitals across the United States.
April 12, 2023
Shahin Z, Shah GH, Apenteng BA, et al. A nationwide study of the "July Effect" concerning postpartum
hemorrhage and its risk factors at teaching hospitals acr…
-
digital.ahrq.gov/principal-investigator/mares-marie-louise
October 11, 2023 - Mares, Marie-Louise
Digital Healthcare Innovations to Engage and Empower Patients in Their Care
Event Date
October 11, 2023 - 12:30pm
- October 11, 2023 - 2:00pm
AHRQ hosted a presentation highlighting how patient engagement in healthcare allows patients and their fam…
-
psnet.ahrq.gov/node/46191/psn-pdf
July 19, 2017 - Performance of a trigger tool for identifying adverse
events in oncology.
July 19, 2017
Lipitz-Snyderman A, Classen D, Pfister D, et al. Performance of a Trigger Tool for Identifying Adverse
Events in Oncology. J Oncol Pract. 2017;13(3). doi:10.1200/jop.2016.016634.
https://psnet.ahrq.gov/issue/performance-trigger…
-
hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/or17.jsp
August 01, 2014 - Overview of Link Plus
An official website of the Department of Health & Human Services
Search All AHRQ Websites
Careers
Contact Us
Espanol
FAQs
Email Updates
…
-
psnet.ahrq.gov/sites/default/files/2022-10/spotlight_case_missed_pneumothorax_10.09.2022_-_final.pdf
January 01, 2022 - Spotlight
Spotlight
False Assumptions Result in a Missed
Pneumothorax after Bronchoscopy with
Transbronchial Biopsy
Source and Credits
• This presentation is based on the September 2022 AHRQ WebM&M
Spotlight Case
o See the full article at https://psnet.ahrq.gov/webmm
o CME credit is available
o Commentary by:…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/nursing-home/resources/infotransNHSOPS.pdf
January 01, 2010 - Nursing Home Survey on Patient Safety Culture: Background and Information for Translators
Agency for Healthcare Research and Quality (AHRQ)
Nursing Home Survey on Patient Safety Culture
Background and Information for Translators
January 2010
Purpose and Use of This Document
In this docum…
-
www.ahrq.gov/sops/international/nursing-home/translators.html
October 01, 2014 - Nursing Home SOPS Translation Information
This document provides information about the Agency for Healthcare Research and Quality (AHRQ) Nursing Home Survey on Patient Safety Culture to help translation team members develop a translation that conveys the same meaning as the original U.S. English version.
Back…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-urinary-retention_disposition-comments.pdf
September 15, 2014 - Report is helpful because clinically, we have been treating CUR
based on “what was always done”. … This report has value
because it highlights the little evidence we have for treating
symtpomatic CUR … We found no data to assess the impact of treating CUR
independent of treating benign prostatic enlargement … We found no data to assess the impact of treating CUR
independent of treating benign prostatic enlargement … However we found no studies of drugs used in
treating CUR in men with BPH and no studies of treating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (1 of 8)
Trikalinos … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (3 of 8)
AChE-I = … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (6 of 8)
Step 3 is … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (7 of 8)
Step 4 in … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (8 of 8)
The fifth
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (1 of 8)
Trikalinos … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (3 of 8)
AChE-I = … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (6 of 8)
Step 3 is … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (7 of 8)
Step 4 in … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (8 of 8)
The fifth
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
January 01, 2009 - interest from the second nominator include combined treatments,
effectiveness of early interventions, treating … Treating commonly associated medical conditions in ASD
a.
-
integrationacademy.ahrq.gov/print/pdf/node/23266
May require fee or membership
Description
Member organization for family physicians with the goal of treating
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Ultra-rapid acting inhaled insulin (Technosphere insulin inhalation system with Afrezza)
for treating … Treating and managing diabetes to prevent complications require patients to make a lifelong
commitment … This led to the reframing of bariatric surgery as
metabolic surgery for treating refractory T2DM in … One such injected
agent is ranibizumab (Lucentis®), which FDA approved in 2012 for treating DME; it … (Alpharetta,
GA).111 In September 2014, FDA approved Iluvien for treating DME in patients “who have